How much profit has Hybrigenics made this year?
Hybrigenics has made -69,160 EUR this year.
Hybrigenics Net Income 2024
Hybrigenics Net Income
-69,160 EUR
Ticker
ALHYG.PA
ISIN
FR0004153930
WKN
A0M9ZU
In 2024, Hybrigenics's profit amounted to -69,160 EUR, a -78.83% increase from the -326,680 EUR profit recorded in the previous year.
The Hybrigenics Net Income history
| YEAR | NET INCOME (undefined EUR) |
|---|---|
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | - |
| 2014 | - |
| 2013 | - |
| 2012 | - |
| 2011 | - |
| 2010 | - |
| 2009 | - |
| 2008 | - |
| 2007 | - |
| 2006 | - |
| 2005 | - |
| 2004 | - |
| 2003 | - |
Hybrigenics Revenue, EBIT, Net Income FR0004153930 · A0M9ZU
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Hybrigenics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Hybrigenics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Hybrigenics’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Hybrigenics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Hybrigenics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Hybrigenics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Hybrigenics’s growth potential.
Hybrigenics Revenue, Profit, and EBIT History
| Date | Hybrigenics Revenue | Hybrigenics EBIT | Hybrigenics Net Income |
|---|---|---|---|
| 2021 | 0 undefined | -123,300 undefined | -69,160 undefined |
| 2020 | -100 undefined | -317,110 undefined | -326,680 undefined |
| 2019 | 234,930 undefined | -1.36 M undefined | -735,510 undefined |
| 2018 | 77,000 undefined | -7.64 M undefined | -7.53 M undefined |
| 2017 | 0 undefined | -7.38 M undefined | -7.96 M undefined |
| 2016 | 1.49 M undefined | -4.02 M undefined | -5.26 M undefined |
| 2015 | 1.16 M undefined | -5 M undefined | -4.38 M undefined |
| 2014 | 5.27 M undefined | -2.48 M undefined | -2.58 M undefined |
| 2013 | 4.98 M undefined | -2.36 M undefined | -1.79 M undefined |
| 2012 | 4.09 M undefined | -3.72 M undefined | -2.45 M undefined |
| 2011 | 6.57 M undefined | -2.72 M undefined | -2.06 M undefined |
| 2010 | 4.54 M undefined | -4.87 M undefined | -4.56 M undefined |
| 2009 | 4.79 M undefined | -4.92 M undefined | -4.19 M undefined |
| 2008 | 4.17 M undefined | -7.18 M undefined | -6.37 M undefined |
| 2007 | 3.37 M undefined | -6.32 M undefined | -6 M undefined |
| 2006 | 3.6 M undefined | -3.94 M undefined | -3.55 M undefined |
| 2005 | 3.61 M undefined | -4.86 M undefined | -5.98 M undefined |
| 2004 | 2.28 M undefined | -5.09 M undefined | -7.42 M undefined |
| 2003 | 2.31 M undefined | -5.66 M undefined | -5.4 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2003 | 2.31 M EUR | -5.66 M EUR | -5.4 M EUR |
| 2004 | 2.28 M EUR | -5.09 M EUR | -7.42 M EUR |
| 2005 | 3.61 M EUR | -4.86 M EUR | -5.98 M EUR |
| 2006 | 3.6 M EUR | -3.94 M EUR | -3.55 M EUR |
| 2007 | 3.37 M EUR | -6.32 M EUR | -6 M EUR |
| 2008 | 4.17 M EUR | -7.18 M EUR | -6.37 M EUR |
| 2009 | 4.79 M EUR | -4.92 M EUR | -4.19 M EUR |
| 2010 | 4.54 M EUR | -4.87 M EUR | -4.56 M EUR |
| 2011 | 6.57 M EUR | -2.72 M EUR | -2.06 M EUR |
| 2012 | 4.09 M EUR | -3.72 M EUR | -2.45 M EUR |
| 2013 | 4.98 M EUR | -2.36 M EUR | -1.79 M EUR |
| 2014 | 5.27 M EUR | -2.48 M EUR | -2.58 M EUR |
| 2015 | 1.16 M EUR | -5 M EUR | -4.38 M EUR |
| 2016 | 1.49 M EUR | -4.02 M EUR | -5.26 M EUR |
| 2017 | 0 EUR | -7.38 M EUR | -7.96 M EUR |
| 2018 | 77,000 EUR | -7.64 M EUR | -7.53 M EUR |
| 2019 | 234,930 EUR | -1.36 M EUR | -735,510 EUR |
| 2020 | -100 EUR | -317,110 EUR | -326,680 EUR |
| 2021 | 0 EUR | -123,300 EUR | -69,160 EUR |
Hybrigenics stock margins FR0004153930 · A0M9ZU
The Hybrigenics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hybrigenics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hybrigenics.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Hybrigenics's sales revenue. A higher gross margin percentage indicates that the Hybrigenics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Hybrigenics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Hybrigenics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Hybrigenics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Hybrigenics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Hybrigenics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Hybrigenics Margin History
| Hybrigenics Gross margin | Hybrigenics Profit margin | Hybrigenics EBIT margin | Hybrigenics Profit margin |
|---|---|---|---|
| 2021 | 99.47 % | 0 % | 0 % |
| 2020 | 99.47 % | 317,110 % | 326,680 % |
| 2019 | 99.47 % | -579.13 % | -313.08 % |
| 2018 | 59.74 % | -9,919.48 % | -9,776.62 % |
| 2017 | 99.47 % | 0 % | 0 % |
| 2016 | 96.31 % | -269.64 % | -352.35 % |
| 2015 | -7.48 % | -429.58 % | -376.18 % |
| 2014 | 24.94 % | -47.07 % | -48.96 % |
| 2013 | 83.5 % | -47.34 % | -35.93 % |
| 2012 | 23.96 % | -90.95 % | -59.9 % |
| 2011 | 93.76 % | -41.4 % | -31.35 % |
| 2010 | 84.58 % | -107.27 % | -100.44 % |
| 2009 | 84.13 % | -102.71 % | -87.47 % |
| 2008 | 84.17 % | -172.18 % | -152.76 % |
| 2007 | 79.53 % | -187.54 % | -178.04 % |
| 2006 | 87.22 % | -109.44 % | -98.61 % |
| 2005 | 84.21 % | -134.63 % | -165.65 % |
| 2004 | 74.12 % | -223.25 % | -325.44 % |
| 2003 | 78.79 % | -245.02 % | -233.77 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2003 | 78.79 % | -245.02 % | -233.77 % |
| 2004 | 74.12 % | -223.25 % | -325.44 % |
| 2005 | 84.21 % | -134.63 % | -165.65 % |
| 2006 | 87.22 % | -109.44 % | -98.61 % |
| 2007 | 79.53 % | -187.54 % | -178.04 % |
| 2008 | 84.17 % | -172.18 % | -152.76 % |
| 2009 | 84.13 % | -102.71 % | -87.47 % |
| 2010 | 84.58 % | -107.27 % | -100.44 % |
| 2011 | 93.76 % | -41.4 % | -31.35 % |
| 2012 | 23.96 % | -90.95 % | -59.9 % |
| 2013 | 83.5 % | -47.34 % | -35.93 % |
| 2014 | 24.94 % | -47.07 % | -48.96 % |
| 2015 | -7.48 % | -429.58 % | -376.18 % |
| 2016 | 96.31 % | -269.64 % | -352.35 % |
| 2017 | 99.47 % | 0 % | 0 % |
| 2018 | 59.74 % | -9,919.48 % | -9,776.62 % |
| 2019 | 99.47 % | -579.13 % | -313.08 % |
| 2020 | 99.47 % | 317,110 % | 326,680 % |
| 2021 | 99.47 % | 0 % | 0 % |
Hybrigenics Aktienanalyse
What does Hybrigenics do?
Hybrigenics SA is a French company that was founded in 1997 to develop innovative technologies for the discovery and development of new drugs. The company specializes in the identification of proteins responsible for the development of cancer and other diseases, as well as the development of therapies for these diseases. It is headquartered in Paris and has branches in the United States and Japan. Hybrigenics has become a leading provider of protein research technologies since its founding, employing approximately 50 employees including scientists, engineers, and technicians. The company's business model is based on developing innovative technologies for drug discovery and development. It conducts research and development in the field of protein research, particularly protein interaction analysis. The company aims to better understand the mechanism of action of proteins involved in disease development in order to develop targeted therapies. Hybrigenics collaborates closely with its customers to develop tailored solutions for their specific research needs. It provides a range of products and services including proteomic services, screening tools, data analysis software, and platform technologies. The company is divided into different divisions, including proteomic services, screening tools, data analysis software, and platform technologies. Some of the key divisions include proteomic services, which offer customers proteomic services based on decades of experience in protein research and analysis. These services allow customers to identify new proteins involved in specific diseases and also provide protein interaction analysis services to better understand the mechanism of action of disease proteins. Hybrigenics offers screening tools that allow customers to quickly and easily investigate and compare different proteins. These tools are particularly useful for identifying proteins that can serve as indicators for specific diseases. The company also offers data analysis software that enables customers to quickly and accurately evaluate the results of their protein research. This software uses algorithms and artificial intelligence to analyze data and identify patterns. Hybrigenics has also developed a range of platform technologies to help customers optimize their protein research. These technologies include the yeast two-hybrid assay, which can be used to study protein interactions, as well as various technologies for protein expression and purification. Hybrigenics offers a variety of products tailored to its different divisions. Some of the key products include the PIII-Toolbox, a comprehensive platform technology for protein research that allows for fast and efficient identification of protein-protein interactions, HybriScreen Plus, a screening tool that helps customers quickly and easily investigate and compare different proteins, and the yeast two-hybrid assay, a platform technology for studying protein interactions to better understand the mechanism of action of disease proteins. Hybrigenics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Hybrigenics's Profit Margins
The profit margins of Hybrigenics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Hybrigenics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Hybrigenics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Hybrigenics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Hybrigenics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Hybrigenics Stock
How has the profit developed compared to last year?
The profit has increased by -78.83% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Hybrigenics publish its earnings?
Hybrigenics publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Hybrigenics?
The profits of Hybrigenics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Hybrigenics?
You can learn more about the earnings of Hybrigenics by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Hybrigenics pay?
Over the past 12 months, Hybrigenics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hybrigenics is expected to pay a dividend of 0 EUR.
What is the dividend yield of Hybrigenics?
The current dividend yield of Hybrigenics is .
When does Hybrigenics pay dividends?
Hybrigenics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Hybrigenics?
Hybrigenics paid dividends every year for the past 0 years.
What is the dividend of Hybrigenics?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Hybrigenics located?
Hybrigenics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Hybrigenics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Hybrigenics from 6/24/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/24/2024.
When did Hybrigenics pay the last dividend?
The last dividend was paid out on 6/24/2024.
What was the dividend of Hybrigenics in the year 2023?
In the year 2023, Hybrigenics distributed 0 EUR as dividends.
In which currency does Hybrigenics pay out the dividend?
The dividends of Hybrigenics are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Hybrigenics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Hybrigenics
Our stock analysis for Hybrigenics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hybrigenics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
